Brief: Hofseth Biocare Q2 EBITDA Loss Widens To NOK 18.3 Mln

Hofseth Biocare ASA

26/08/2022 07:14

Aug 26 (Reuters) - Hofseth Biocare ASA  HBC.OL :
    * GROSS OPERATING REVENUES OF NOK 25.8M (31.0M) IN Q2
    * Q2 OPERATING RESULT (EBITDA) WAS NOK -18.3M (-14.6M)

Source text for Eikon:  ID:nGNE4Qymnw 
Further company coverage:  HBC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))